Correa-Valdez M

Idioma: Español
Referencias bibliográficas: 10
Paginas: 192-194
Archivo PDF: 748.86 Kb.

FRAGMENTO

La enfermedad renal crónica (ERC) se ha consolidado en las últimas décadas como un importante problema de salud pública a nivel mundial. Más allá de sus implicaciones renales, la ERC se asocia con un incremento significativo del riesgo cardiovascular, el cual constituye la principal causa de morbimortalidad en esta población.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, etal. Cardiorenal syndrome: classification, pathophysiology, diagnosis,and treatment strategies: a scientific statement from the American HeartAssociation. Circulation. 2019;139:e840-e878.

2. House AA, Wanner C, Sarnak MJ. Chronic kidney disease andcardiovascular disease: epidemiology and management. Kidney Int.2024;105:1219-1230.

3. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO2024 Clinical practice guideline for the evaluation and management ofchronic kidney disease. Kidney Int. 2024;105:S117-S314. doi: 10.1016/j.kint.2023.10.018.

4. Thompson A, Fleischmann KE, Smilowitz NR, de Las Fuentes L,Mukherjee D, Aggarwal NR, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM guideline for perioperative cardiovascularmanagement for noncardiac surgery: a report of the American Collegeof Cardiology/American Heart Association Joint Committee on clinicalpractice guidelines. Circulation. 2024;150:e351-e442. doi: 10.1161/CIR.0000000000001285.

5. Cohn SL. 2024 ACC/AHA guideline on perioperative cardiovascularmanagement before noncardiac surgery: what’s new? Cleve Clin J Med.2025;92:213-219.

6. Palamuthusingam D, Pascoe EM, Hawley CM, Johnson DW, Fahim M.Revised cardiac risk index in predicting cardiovascular complicationsin patients receiving chronic kidney replacement therapy undergoingelective general surgery. Perioper Med (Lond). 2024;13:70.

7. deFilippi CR, Herzog CA. Interpreting cardiac troponin results in chronickidney disease. Circulation. 2023;63:59-65.

8. Matsushita K, Ballew SH, Coresh J. Cardiovascular risk predictionin people with chronic kidney disease. Curr Opin Nephrol Hypertens.2016;25:518-523.

9. Moscucci M, Eagle KA. Coronary revascularization before noncardiacsurgery. N Engl Med. 2004;351:2861-2863.

10. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation ofrenal disease in randomized controlled trials of cardiovascular disease.JAMA. 2006;296:1377-1384.